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Caspase-2, one of the earliest discovered caspases, has emerged as a multifunctional enzyme with roles that are not
limited to cell death. It acts as a tumor suppressor, prevents genetic instability, and protects against aging by playing a
crucial role in sensing alterations in cellular redox status and activating the antioxidant defense system. These apparent
non-apoptotic functions, only discovered recently, emphasize the importance of this often-neglected protease.
Since its discovery almost 2 decades
ago,1 caspase-2 has intrigued the scientific
community. It is activated in response to
diverse apoptotic stimuli both upstream
and downstream of mitochondrial outer
membrane permeabilization (MOMP)
and, unlike many other proteins, can initi-
ate cell death even in the absence of
reported adaptor proteins such as p53-
induced protein with a death domain
(PIDD) and RIP-associated ICH-1
homologous protein with a death domain
(RAIDD). Furthermore, caspase-2 has
been implicated in several other roles
including tumor suppression, mainte-
nance of genetic stability, autophagy, and
aging.2,3
Recent studies from our laboratory
indicate that caspase-2 knockout
(Casp2¡/¡) mice have a reduced maxi-
mum lifespan and show early onset of sev-
eral aging related traits.4 This was in
agreement with a previous study using
Casp2¡/¡ mice that were generated inde-
pendently.5 Aged Casp2¡/¡ mice had
reduced body weight and bone volume
and showed early hair graying and reduced
subcutaneous fat thickness.4 Interestingly,
no spontaneous tumor formation was evi-
dent as these mice aged. However, several
aged Casp2¡/¡ mice developed spleno-
megaly and had prominent lymphocytic
infiltration in the liver.4 One of our key
observations was that aged Casp2¡/¡ mice
experienced oxidative stress and showed
evidence of increased oxidative DNA
damage in the liver. The activity of the
antioxidant enzymes superoxide dismutase
(SOD) and glutathione peroxidase (GSH-
Px) was reduced with a concomitant
increase in protein and lipid oxidation. In
order to understand this further we used
ethanol as an oxidative challenge. Adult
mice were fed a diet containing ethanol,
and both wild-type (WT) and Casp2¡/¡
mice showed increased steatosis and liver
damage. Interestingly, Casp2¡/¡ mice did
not show any increase in SOD and GSH-
Px activity. These results suggest that cas-
pase-2 acts as a cellular sensor for reactive
oxygen species (ROS). In the absence of
caspase-2, cells fail to respond to exoge-
nous oxidative challenge by upregulating
the protective antioxidant mechanisms.4
This results in more oxidative damage in
Casp2¡/¡ mice and the prolonged expo-
sure to stress causes accumulation of dam-
aged cells, leading to the functional
decline that is often associated with aging.
We extended these observations using
another robust free radical generator,
paraquat (PQ).6 Paraquat is a widely-used
superoxide radical generator that primarily
affects the lungs. In this study we included
a cohort that received the antioxidant,
N-acetyl cysteine (NAC). NAC was
administered prior to PQ injection and
the mice had ad libitum access for the
entire 2-week observation time post PQ
injection. We observed that pulmonary
lesions in Casp2¡/¡ mice were consistently
more severe than those in WT mice. Cas-
pase-2 was activated in response to PQ,
and NAC prevented its activation. How-
ever, even though caspase-2 was not acti-
vated, cellular damage occurred in the
NAC supplemented group and only par-
tial rescue was observed by histology of
lung and liver tissue.6 It is important to
highlight that a very mild dose of PQ
(15 mg/kg body weight) was used because
higher doses are fatal. The benefit of a low
dose is that it allows time to monitor ani-
mal heath (such as acute body weight loss
or respiratory distress), which was not dif-
ferent between the 2 genotypes. In addi-
tion, subtle differences are difficult to
demarcate with a high dose that causes
extensive damage. Similar to our previous
observations, induction of SOD and
GSH-Px was not observed in PQ-treated
Casp2¡/¡ mice.6 Expression of forkhead
homeobox type O (Foxo), SOD2, and
nuclear factor erythroid 2-related factor 2
(Nrf2) was significantly reduced in the
lungs of Casp2¡/¡ mice. The two major
observations were: (1) PQ-induced stress
caused karyomegaly and binucleation in
Casp2¡/¡ mouse liver in a dose-dependent
manner. Although the liver is not the pri-
mary target tissue, it is the seat of metabo-
lism where the effects on nuclear size were
easy to identify; and (2) Caspase-2 pre-
vented the inflammatory response as
serum IL6 and IL-1b levels were higher in
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PQ-injected Casp2¡/¡ mice compared to
WT.6
Loss of caspase-2 increases genomic
instability and predisposes mice to thymo-
mas, lymphomas, and MMTV-induced
mammary tumors, which display karyo-
megaly and aberrant mitosis (reviewed in
ref.7).7,8 The fact that Casp2¡/¡ mice
develop cell cycle defects earlier and in
response to low doses of the stressor
strengthens our hypothesis that Casp2¡/¡
mice have reduced stress tolerance and a
compromised background that makes
them more susceptible to various oxidative
and oncogenic stimuli. This may at least
partially account for the early aging phe-
notype in these mice.
Surprisingly, we also observed increased
Jun N-terminal kinase (JNK) activation
without any increased cell death in
PQ-treated Casp2¡/¡ mice. The increase
in JNK activity may be an adaptive
response in cells lacking caspase-2 (i.e.,
these cells rely on another stress sensor)
and/or may simply indicate higher ROS
production/oxidative stress in these cells,
which forces activation of other redox sen-
sitive pathways even under mild stress
whereas it evokes no such response in WT
mice. It is very likely that increased stress
in Casp2¡/¡ mice independently activates
JNK, which may prevent oxidative stress
while also activating the inflammatory
response that would account for the ele-
vated IL6 and IL-1b levels in Casp2¡/¡
mice.6
To identify the cause of the increased
ROS, we analyzed mitochondria, the chief
cellular ROS generators. Hepatic mito-
chondria from 12-month-old Casp2¡/¡
mice (middle aged) were identical in per-
formance to those from 24-month-old
WT mice (old); moreover, the Casp2¡/¡
mice had increased complex III activity.9
Using several distinct approaches, caspase-
2 has been implicated as a fine-tuner of
several metabolic processes during aging.
Several enzymes involved in carbohydrate
metabolism are upregulated, whereas ribo-
somal and respiratory complex proteins
are downregulated.10 Similar to the previ-
ous study, the metabolic profile changes
occurring in the young Casp2¡/¡ mice
resemble those found in aged WT mice,
indicating that mitochondrial dysfunction
is another likely contributor to premature
aging in Casp2¡/¡ mice.
In the absence of unique caspase-2 sub-
strates involved in redox regulation, is it
not possible to pinpoint the exact mecha-
nism by which caspase-2 prevents oxida-
tive damage, although some affected
proteins/enzymes/pathways have now
been identified (Fig. 1). Nevertheless, the
protective roles of caspase-2 in oxidative
stress management and prevention of
aging are now clearly established by the
recent in vivo studies summarized in this
article.
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Figure 1. Possible role of caspase-2 in protecting against oxidative stress. Caspase-2 is normally
activated in response to oxidants/reactive oxygen species (ROS), thus preventing oxidative stress.
In cells lacking caspase-2, the threshold to withstand stress is reduced and accumulation of cells
with dysfunctional mitochondria, binucleation, and karyomegaly is often observed, perhaps as a
result of perturbed cell cycling. Expression of the antioxidant responsive genes Foxo and Nrf2 is
reduced and no increase in SOD and GSH-Px enzyme activity occurs to counteract the oxidative
challenge. As a result there is increased oxidative damage to proteins and DNA, and such cells pro-
duce more ROS. This activates other redox-sensitive proteins such as JNK, increasing the secretion
of some inﬂammatory cytokines. Thus, increased oxidative stress probably causes the aging pheno-
type observed in caspase-2 knockout mice.
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